![]()
|
|
||||||||
J. Biol. Chem., Vol. 255, Issue 22, 10758-10763, Nov, 1980
LH Caporale, PS Tippett, BW Erickson and TE Hugli
The essential active site responsible for the inflammatory activities of
C3a, an anaphylatoxin derived from the serum complement system, has been
elucidated using C3a peptides synthesized by the solid phase method and
assayed for their ability to contract guinea pig ileal tissue and to
produce a wheal and flare response in human skin. The COOH-terminal C3a
pentapeptide (Leu-Gly-Leu-Ala-Arg) common to rat, pig, and man shows
vascular and smooth muscle activity as well as specificity similar to
natural human C3a. The porcine C3a octapeptide is 3 times more active than
the common pentapeptide, but the human octapeptide
(Ala(70)-Ser-His-Leu(73)-Gly-Leu(75)-Ala-Arg(77) is 12 times more active
than the pentapeptide. Replacement of the serine and histidine by alanine
or acetylation of the NH2 terminus provides analogues with the same
activity as the octapeptide. Thus, the increased activity of the human C3a
octapeptide over the pentapeptide appears to be related to the backbone of
residues 70 to 72 and is not due to the presence of the hydroxyl group of
serine-71, the imidazole ring of histidine-72, or a positive charge at or
near the NH2 terminus. Since the COOH-terminal tetrapeptide is 40 times
less active than the pentapeptide, an adequate model of the essential
active site of C3a anaphylatoxin is the common COOH-terminal pentapeptide
region. A C3a active site analogue containing a COOH-terminal lysyl residue
is devoid of ileal activity. In addition, the [alanine-73]pentapeptide is 9
times less active and the [alanine-75]pentapeptide is at least 70 times
less active than the active site pentapeptide in the ileal assay. Thus, the
hydrophobic side chains of leucine-73 and leucine-75 and the guanidinium
group of arginine-77 are important for the contractile activity of the
active site COOH-terminal pentapeptide of human C3a anaphylatoxin.
The active site of C3a anaphylatoxin
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
E. A. Nordahl, V. Rydengard, P. Nyberg, D. P. Nitsche, M. Morgelin, M. Malmsten, L. Bjorck, and A. Schmidtchen Activation of the complement system generates antibacterial peptides PNAS, November 30, 2004; 101(48): 16879 - 16884. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Wittamer, F. Gregoire, P. Robberecht, G. Vassart, D. Communi, and M. Parmentier The C-terminal Nonapeptide of Mature Chemerin Activates the Chemerin Receptor with Low Nanomolar Potency J. Biol. Chem., March 12, 2004; 279(11): 9956 - 9962. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Pinto, C. M. Chinnici, Y. Kimura, D. Melillo, R. Marino, L. A. Spruce, R. De Santis, N. Parrinello, and J. D. Lambris CiC3-1a-Mediated Chemotaxis in the Deuterostome Invertebrate Ciona intestinalis (Urochordata) J. Immunol., November 15, 2003; 171(10): 5521 - 5528. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Ames, D. Lee, J. J. Foley, A. J. Jurewicz, M. A. Tornetta, W. Bautsch, B. Settmacher, A. Klos, K. F. Erhard, R. D. Cousins, et al. Identification of a Selective Nonpeptide Antagonist of the Anaphylatoxin C3a Receptor That Demonstrates Antiinflammatory Activity in Animal Models J. Immunol., May 15, 2001; 166(10): 6341 - 6348. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Petering, J. Kohl, A. Weyergraf, Y. Dulkys, D. Kimmig, R. Smolarski, A. Kapp, and J. Elsner Characterization of Synthetic C3a Analog Peptides on Human Eosinophils in Comparison to the Native Complement Component C3a J. Immunol., April 1, 2000; 164(7): 3783 - 3789. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |